GSE239651 ispinesib 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239651_ispinesib_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239651_ispinesib_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239651_ispinesib_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239651_ispinesib_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

general transcription factor IIi pseudogene 1

Gene

prostate cancer associated transcript 7

Gene

JPX transcript, XIST activator

Gene

B3GALT5 antisense RNA 1

Gene

SOX2 overlapping transcript

Gene

MIR3936 host gene

Gene

long intergenic non-protein coding RNA 1122

Gene

uncharacterized LOC105377198

Gene

eukaryotic translation elongation factor 1 gamma pseudogene 5

Gene

long intergenic non-protein coding RNA 1533

  • Gene

    general transcription factor IIi pseudogene 1


  • Gene

    prostate cancer associated transcript 7


  • Gene

    JPX transcript, XIST activator


  • Gene

    B3GALT5 antisense RNA 1


  • Gene

    SOX2 overlapping transcript



  • Gene

    long intergenic non-protein coding RNA 1122


  • Gene

    uncharacterized LOC105377198


  • Gene

    eukaryotic translation elongation factor 1 gamma pseudogene 5


  • Gene

    long intergenic non-protein coding RNA 1533

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.